Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Amplification of poly(I:C)-induced interleukin-6 production in human bronchial epithelial cells by priming with interferon-γ. | Sci Rep | 2023 | 38030681 | PubTator, text mining | PubMed |
| Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival. | Blood Cancer J | 2023 | 38030619 | PubTator, text mining | PubMed |
| Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis. | iScience | 2023 | 38026226 | PubTator, text mining | PubMed |
| Mendelian susceptibility to mycobacterial diseases: State of the puzzle. | Qatar Med J | 2023 | 38025345 | PubTator, text mining | PubMed |
| Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. | Front Mol Neurosci | 2023 | 38025266 | PubTator, text mining | PubMed |
| Editorial: Advances in therapeutic strategies of inborn errors of immunity. | Front Immunol | 2023 | 38022641 | PubTator, text mining | PubMed |
| A Machine Learning-Based Classification of Immunogenic Cell Death Regulators and Characterisation of Immune Microenvironment in Acute Ischemic Stroke. | Int J Clin Pract | 2023 | 38020537 | PubTator, text mining | PubMed |
| Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor. | Front Med (Lausanne) | 2023 | 38020179 | PubTator, text mining | PubMed |
| RIPK3 promotes brain region-specific interferon signaling and restriction of tick-borne flavivirus infection. | PLoS Pathog | 2023 | 38011306 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapies for psoriasis. | Signal Transduct Target Ther | 2023 | 38008779 | PubTator, text mining | PubMed |
| Ruxolitinib attenuates acute rejection and can serve as an immune induction therapy in heart transplantation. | Clin Immunol | 2023 | 38008145 | PubTator, text mining | PubMed |
| Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines. | Vaccines (Basel) | 2023 | 38006022 | PubTator, text mining | PubMed |
| Placental inflammatory cytokines mRNA expression and preschool children's cognitive performance: a birth cohort study in China. | BMC Med | 2023 | 37981714 | PubTator, text mining | PubMed |
| E3 ligase Trim35 inhibits LSD1 demethylase activity through K63-linked ubiquitination and enhances anti-tumor immunity in NSCLC. | Cell Rep | 2023 | 37979167 | PubTator, text mining | PubMed |
| Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis. | J Transl Med | 2023 | 37978524 | PubTator, text mining | PubMed |
| SEPTIN2 suppresses an IFN-γ-independent, proinflammatory macrophage activation pathway. | Nat Commun | 2023 | 37978190 | PubTator, text mining | PubMed |
| New insights into the genetic predisposition of brucellosis and its effect on the gut and vaginal microbiota in goats. | Sci Rep | 2023 | 37973848 | PubTator, text mining | PubMed |
| IFN-γ lowers tumor growth by increasing glycolysis and lactate production in a nitric oxide-dependent manner: implications for cancer immunotherapy. | Front Immunol | 2023 | 37965321 | PubTator, text mining | PubMed |
| Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood. | bioRxiv | 2023 | 37961682 | PubTator, text mining | PubMed |
| Developments in Genetics: Better Management of Ovarian Cancer Patients. | Int J Mol Sci | 2023 | 37958970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers?page=13